AIM ImmunoTech Converts ~$400,000 of Debt Into 1.75M Shares With Streeterville Capital
AIM ImmunoTech completed two debt-for-equity exchanges with Streeterville Capital on September 8 and 9, 2026, converting approximately $400,000 of principal from a November 18, 2025 promissory note into 1,749,434 shares of common stock. The average conversion price was about $0.228 per share. The e…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.